Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection.


Journal

Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858

Informations de publication

Date de publication:
08 2020
Historique:
received: 18 01 2020
revised: 21 03 2020
accepted: 13 04 2020
pubmed: 20 5 2020
medline: 15 12 2020
entrez: 20 5 2020
Statut: ppublish

Résumé

Changes in the cellular microenvironment play a critical role in the development of bladder cancer (BC). Yes-associated protein (YAP), a central mediator of the Hippo pathway, functions as a nuclear sensor of mechanotransduction that can be induced by stiffness of the extracellular matrix (ECM), including stiffness resulting from surgical manipulations. We aimed to clarify the possible association between surgically-related ECM stiffness and YAP activation in BC patients. We compared 30 bladder cancer tissues with grade II (n = 15 recurrent and n = 15 newly diagnosed) with 30 adjacent healthy tissues. Atomic force microscopy showed that patients with recurrent BC had stiffer ECM than newly diagnosed patients (P < 0.05). Gene expression profiles showed that β1 integrin (ITGB1), focal adhesion kinase (FAK), CDC42, and YAP were upregulated in cancerous tissues (P < 0.05); additionally, β1 integrin activation was confirmed using a specific antibody. Nuclear localization of YAP was higher in recurrent cancerous tissues compared with newly diagnosed and it was positively associated with higher stiffness (P < 0.05). Our results suggest that postsurgery-induced ECM stiffness can influence integrin-FAK-YAP activity and thereby YAP trafficking to the nucleus where it contributes to BC progression and relapse.

Identifiants

pubmed: 32428277
doi: 10.1111/nyas.14358
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Biomarkers, Tumor 0
Transcription Factors 0
YAP-Signaling Proteins 0
YAP1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-61

Informations de copyright

© 2020 New York Academy of Sciences.

Références

Sanli, O., J. Dobruch, M.A. Knowles, et al. 2017. Bladder cancer. Nat. Rev. Dis. Primers 3: 17022.
Sylvester, R.J., W. Oosterlinck, S. Holmang, et al. 2016. Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after TR with TR alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur. Urol. 69: 231-244.
Hofer, S., G. Molema, R. Hermens, et al. 1999. The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol. 25: 231-243.
Goldfarb, Y. & S. Ben-Eliyahu. 2007. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 26: 99-114.
Gailit, J. & R.A. Clark. 1994. Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6: 717-725.
Xue, M. & C.J. Jackson. 2015. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv. Wound Care 4: 119-136.
Zhou, S., J. Salisbury, V.R. Preedy, et al. 2013. Increased collagen synthesis rate during wound healing in muscle. PLoS One 8: e58324.
Chakraborty, S. & W. Hong. 2018. Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond. Cancers 10: 45.
Seong, J., N. Wang & Y. Wang. 2013. Mechanotransduction at focal adhesions: from physiology to cancer development. J. Cell. Mol. Med. 17: 597-604.
Szarvas, T., V. László, F. Vom Dorp, et al. 2012. Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer. Int. J. Cancer 130: 2922-2929.
Wei, B., X. Zhou, C. Liang, et al. 2017. Human colorectal cancer progression correlates with LOX-induced ECM stiffening. Int. J. Biol. Sci. 13: 1450.
Zhu, H., H. Chen, J. Wang, et al. 2019. Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer. Onco Targets Ther. 12: 3441.
Du, J., X. Chen, X. Liang, et al. 2011. Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity. Proc. Natl. Acad. Sci. USA 108: 9466-9471.
Chin, L., Y. Xia, D.E. Discher & P.A. Janmey. 2016. Mechanotransduction in cancer. Curr. Opin. Chem. Eng. 11: 77-84.
Taylor, M.A., J.D. Amin, D.A. Kirschmann & W.P. Schiemann. 2011. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. Neoplasia (New York, NY) 13: 406.
Noguchi, S., A. Saito & T. Nagase. 2018. YAP/TAZ signaling as a molecular link between fibrosis and cancer. Int. J. Mol. Sci. 19: 3674.
Moroishi, T., C.G. Hansen & K.-L. Guan. 2015. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15: 73.
Panciera, T., L. Azzolin, M. Cordenonsi & S. Piccolo. 2017. Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18: 758.
Elbediwy, A. & B.J. Thompson. 2018. Evolution of mechanotransduction via YAP/TAZ in animal epithelia. Curr. Opin. Cell Biol. 51: 117-123.
Wei, S.C., L. Fattet, J.H. Tsai, et al. 2015. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat. Cell Biol. 17: 678.
Hytönen, V.P. & B. Wehrle-Haller. 2016. Mechanosensing in cell-matrix adhesions-converting tension into chemical signals. Exp. Cell Res. 343: 35-41.
Arnaout, M.A., S.L. Goodman & J.-P. Xiong. 2007. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 19: 495-507.
Hicks-Berthet, J. & X. Varelas. 2017. Integrin-FAK-CDC42-PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells. Bioessays 39. https://doi.org/10.1002/bies.201700116.
Hu, J.K.-H., W. Du, S.J. Shelton, et al. 2017. An FAK-YAP-mTOR signaling axis regulates stem cell-based tissue renewal in mice. Cell Stem Cell 21: 91-106.e6.
Liu, Y., G. Wang, Z. Liang, et al. 2018. Lysyl oxidase: a colorectal cancer biomarker of lung and hepatic metastasis. Thorac. Cancer 9: 785-793.
Acerbi, I., L. Cassereau, I. Dean, et al. 2015. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr. Biol. 7: 1120-1134.
Held, A., M. Bollmann, U. Hansen, et al. 2019. Inhibition of SDC4-LOX mediated extracellular matrix stiffening prevents chondrocyte differentiation in OA cartilage via increased YAP/TAZ signaling. Osteoarthritis Cartilage 27: S150-S151.
Noto, A., C. De Vitis, M.E. Pisanu, et al. 2017. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Oncogene 36: 4573.
Humphrey, P.A., H. Moch, A.L. Cubilla, et al. 2016. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur. Urol. 70: 106-119.
Ji, J., R. Xu, X. Zhang, et al. 2018. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ. Cell Death Dis. 9: 517.
Ceccarelli, D.F., H.K. Song, F. Poy, et al. 2006. Crystal structure of the FERM domain of focal adhesion kinase. J. Biol. Chem. 281: 252-259.
Calvo, F., N. Ege, A. Grande-Garcia, et al. 2013. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15: 637.
Burger, M., J.W. Catto, G. Dalbagni, et al. 2013. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 63: 234-241.
Berrum-Svennung, I., T. Granfors, S. Jahnson, et al. 2008. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. J. Urol. 179: 101-106.
Dupont, S., L. Morsut, M. Aragona, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179.
Lv, H., L. Li, M. Sun, et al. 2015. Mechanism of regulation of stem cell differentiation by matrix stiffness. Stem Cell Res. Ther. 6: 103.
Stuelten, C.H., A. Barbul, J.I. Busch, et al. 2008. Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism. Cancer Res. 68: 7278-7282.
Divrik, R.T., Y. Üt, F. Zorlu & H. Özen. 2006. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J. Urol. 175: 1641-1644.
Hoyt, K., B. Castaneda, M. Zhang, et al. 2008. Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark. 4: 213-225.
Goetz, J.G., S. Minguet, I. Navarro-Lérida, et al. 2011. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 146: 148-163.
Krouskop, T.A., T.M. Wheeler, F. Kallel, et al. 1998. Elastic moduli of breast and prostate tissues under compression. Ultrason. Imaging 20: 260-274.
Lekka, M., D. Gil, K. Pogoda, et al. 2012. Cancer cell detection in tissue sections using AFM. Arch. Biochem. Biophys. 518: 151-156.
Hayashi, K. & M. Iwata. 2015. Stiffness of cancer cells measured with an AFM indentation method. J. Mech. Behav. Biomed. Mater. 49: 105-111.
Levental, K.R., H. Yu, L. Kass, et al. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
Ulrich, T.A., E.M. de Juan Pardo & S. Kumar. 2009. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res. 69: 4167-4174.
Brooks, M., Q. Mo, R. Krasnow, et al. 2016. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget 7: 82609.
Rizwan, A., C. Bulte, A. Kalaichelvan, et al. 2015. Metastatic breast cancer cells in lymph nodes increase nodal collagen density. Sci. Rep. 5: 10002.
Ng, M.R. & J.S. Brugge. 2009. A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell 16: 455-457.
Ciamporcero, E., M. Daga, S. Pizzimenti, et al. 2018. Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer. Free Radic. Biol. Med. 115: 447-457.
Wang, Y., Q. Dong, Q. Zhang, et al. 2010. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 101: 1279-1285.
Meng, Z., T. Moroishi & K.-L. Guan. 2016. Mechanisms of Hippo pathway regulation. Genes Dev. 30: 1-17.
Chakraborty, S., K. Njah, A.V. Pobbati, et al. 2017. Agrin as a mechanotransduction signal regulating YAP through the Hippo pathway. Cell Rep. 18: 2464-2479.
Shen, Z. & B.Z. Stanger. 2015. YAP regulates S-phase entry in endothelial cells. PLoS One 10: e0117522.
Dupont, S. 2016. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp. Cell Res. 343: 42-53.
Goel, H.L., J. Li, S. Kogan & L.R. Languino. 2008. Integrins in prostate cancer progression. Endocr. Relat. Cancer 15: 657.
Danen, E.H. 2005. Integrins: regulators of tissue function and cancer progression. Curr. Pharm. 11: 881-891.
Cox, T.R. & J.T. Erler. 2011. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Models Mech. 4: 165-178.

Auteurs

Hadi Ghasemi (H)

Department of Clinical Biochemistry, Hamadan University of Medical Sciences, Hamadan, Iran.

Seyed Habibollah Mousavibahar (SH)

Urology & Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Mohammad Hashemnia (M)

Department of Pathobiology, Veterinary Medicine Faculty Razi University, Kermanshah, Iran.

Jamshid Karimi (J)

Department of Clinical Biochemistry, Hamadan University of Medical Sciences, Hamadan, Iran.

Iraj Khodadadi (I)

Department of Clinical Biochemistry, Hamadan University of Medical Sciences, Hamadan, Iran.

Fatemeh Mirzaei (F)

Department of Anatomy, Hamadan University of Medical Sciences, Hamadan, Iran.

Heidar Tavilani (H)

Urology & Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH